6 ms·

There is also https://loyal.com https://loyal.com - Biotech Startup for researching/ developing longevity drugs for dogs.

• LeifCarrotson 2y ago
  I was also going to link Loyal, I think they came up on HN last year and had some good discussion: https://news.ycombinator.com/item?id=38447491 https://news.ycombinator.com/item?id=38447491 There's also https://leapyears.com/ https://leapyears.com/ - another project with similar goals. That one is associated with David Sinclair of Harvard Medical School: https://sinclair.hms.harvard.edu/people/david-sinclair https://sinclair.hms.harvard.edu/people/david-sinclair Personally, I'm optimistic about the capacity of studies and projects like these to extend our knowledge regarding aging. Human trials are fraught with ethical issues, and have very slow feedback loops (acquiring results from a study might take decades, which can be an entire career). Laboratory trials on mice and other small mammals can be more effective, but funding is hard and the results are isolated to a small academic lab. Large-scale supplements for pets can give data in a few years, have lesser (though not negligible) ethical problems, and have built-in funding. The funding process is, of course, a source of conflicts of interest, but it has to be done somehow.